Accretive Health (AH) Files $200M IPO
Down)
Accretive Health, Inc. (NYSE: AH) filed for an IPO on form S-1 with a proposed maximum aggregate offering price of $200 million. The company plans to list on the NYSE under the symbol "AH".
Underwriters of the offering include Goldman Sachs, Credit Suisse, JP Morgan and Morgan Stanley.
Accretive Health is a leading provider of healthcare revenue cycle management services. Our business purpose is to help U.S. hospitals, physicians and other healthcare providers manage their revenue cycle operations more efficiently. Our integrated, end-to-end technology and services offering, which we refer to as our solution, helps our customers realize sustainable improvements in their operating margins and improve the satisfaction of their patients, physicians and staff. We enable these improvements by helping our customers increase the portion of the maximum potential patient revenue they receive while reducing total revenue cycle costs.
Underwriters of the offering include Goldman Sachs, Credit Suisse, JP Morgan and Morgan Stanley.
Accretive Health is a leading provider of healthcare revenue cycle management services. Our business purpose is to help U.S. hospitals, physicians and other healthcare providers manage their revenue cycle operations more efficiently. Our integrated, end-to-end technology and services offering, which we refer to as our solution, helps our customers realize sustainable improvements in their operating margins and improve the satisfaction of their patients, physicians and staff. We enable these improvements by helping our customers increase the portion of the maximum potential patient revenue they receive while reducing total revenue cycle costs.
You May Also Be Interested In
- TRIA Beauty (TRIA) Postponses IPO, Cites Market Conditions
- More than 87M shares of Facebook (FB) have already traded
- Intelsat Global Holdings SA (I) Files $1.75B IPO
Create E-mail Alert Related Categories
IPOsRelated Entities
Credit Suisse, JPMorgan, Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
